4//SEC Filing
LEONARD JOHN M 4
Accession 0001193125-25-317551
CIK 0001652130other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:09 PM ET
Size
16.9 KB
Accession
0001193125-25-317551
Insider Transaction Report
Form 4
LEONARD JOHN M
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-11$6.83/sh+49,959$341,220→ 1,127,074 total - Sale
Common Stock
2025-12-11$9.49/sh−49,959$474,111→ 1,077,115 total - Sale
Common Stock
2025-12-11$9.47/sh−32,832$310,919→ 1,044,283 total - Sale
Common Stock
2025-12-11$9.59/sh−5,355$51,354→ 1,038,928 total - Exercise/Conversion
Common Stock
2025-12-12$6.83/sh+8,557$58,444→ 1,047,485 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-11−49,959→ 8,557 totalExercise: $6.83Exp: 2026-02-03→ Common Stock (49,959 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-12-12−8,557→ 0 totalExercise: $6.83Exp: 2026-02-03→ Common Stock (8,557 underlying)
Holdings
- 58,415(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sales reported on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $9.64, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.57, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.57 to $9.65, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 11, 2025 at each separate price.
- [F5]Shares held by the John M. Leonard 2015 Irrevocable Trust.
- [F6]The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested in full as of December 11, 2025.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001563584
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:09 PM ET
- Size
- 16.9 KB